Verde Media Group, Inc. has announced the initial product line from its majority-owned subsidiary, Beautyject Inc. Comprised of a slate of needle-free, over-the-counter cosmetic injectables, this new product line is poised for its North American release by a top-tier sales and marketing firm and comfortably occupies its own niche in the industry.
For the first time ever, individuals will be able to administer treatments for superficial lines, minor skin damage, fine wrinkles, moisture and skin elasticity from home or by a beautician, with no risk of needle stick injuries and damage to the skin.
The Beautyject homecare and beautician initial line will consist of the following products:
• The Wrinkle-Ject - Non cross-linked hyaluronic acid sterile gel for removal of superficial lines, fine wrinkles and minor skin damage to the face.
• The Stretch-Ject - Combination of hyaluronic acid and vitamins to help reduce the appearance of scars and stretch marks by increasing the skins moisture and elasticity.
• The Glow-Ject - Used to immediately improve the skins radiance. Along with the above product lines, the Company will provide a variety of products specifically targeted to the professional market containing higher doses of hyaluronic acid, vitamin C, B12, B6 and more to treat age spots, sun marks, scars and other skin deficiencies. Although these formulations do not require FDA approval, given their higher concentration a certified physician must administer them. In addition, the Company’s B-Ject injectors are also compatible with various FDA approved drugs such as Botox. The company is currently preparing to launch its marketing and distribution campaign with Power Shark Capital. Powershark Capital is a coordinated effort of global entrepreneur, Jean Jean Pelletier and advertising guru Kevin Harrington, popularly known as star of the network television show, Shark Tank. The group has a storied history of experience in business and advertising, Mr. Harrington having personally sold more than $4 Billion worth of products through television-based promotional campaigns and defining the infomercial industry as it is known today.
About Beautyject, Inc.
Beautyject, Inc. is a majority owned subsidiary of Verde Media and offers needle-free technology fully adapted to the beauty care and cosmetic markets. The injectors can be used to administer liquid cosmetic products such as Botox, hyaluronic acid, vitamins, and a variety of other products cocktails to the top layers of the skin through a non-invasive, needle-free, painless delivery system. It expects revenues to reach upwards of $25 million by its third year of commercialization.
About Verde Media Group Inc.
Verde Media Group Inc. (verdemediagroup.com) is a publicly traded company listed on the OTC Markets trading under the stock symbol: VMGI.
Verde Media Group Inc. The company consists of three divisions: Agency Division- The innovative Agency division services- public relations, marketing, and transaction functions for corporate clientele. BioTech Division- The Biotech Division manages a portfolio of biotech companies and the VMBD division undertakes the business of developing and producing high value bio-products from renewable biomass. The focus and criterion is to develop proprietary microbial technologies with low risk scale-up methods employing low cost feedstock. Entertainment Division- The company operates a managed media company with production, distribution, development, and acquisition functions for film and television.
DISCLAIMER: CAUTIONARY DISCLOSURE About FORWARD-LOOKING STATEMENTS The results described herein cannot be guaranteed. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are "forward-looking statements" that are based on current expectations and assumptions.